Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jolyon H Hendry

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 25, 2014
A modelled comparison of prostate cancer control rates after high-dose-rate brachytherapy (3145 multicentre patients) combined with, or in contrast to, external-beam radiotherapyStephen A Roberts, Raymond Miralbell, Eduardo H Zubizarreta, et al.
Cardiovascular Research|June 15, 2004
Biological aspects of radiation and drug-eluting stents for the prevention of restenosisJürgen R Sindermann, Vitali Verin, John W Hopewell, et al.
International Journal of Radiation Oncology, Biology, Physics|January 31, 2004
The bioreductive agent RH1 and gamma-irradiation both cause G2/M cell cycle phase arrest and polyploidy in a p53-mutated human breast cancer cell lineJoo-Young Kim, Chul-Hwan Kim, Ian J Stratford, et al.
International Journal of Radiation Oncology, Biology, Physics|April 16, 2003
Prediction of the benefits from dose-escalated hypofractionated intensity-modulated radiotherapy for prostate cancerAli M Amer, Judith Mott, Ranald I Mackay, et al.
Journal of Radiological Protection : Official Journal of the Society for Radiological Protection|May 21, 2009
Human exposure to high natural background radiation: what can it teach us about radiation risks?Jolyon H Hendry, Steven L Simon, Andrzej Wojcik, et al.
International Journal of Radiation Oncology, Biology, Physics|January 18, 2006
Tumor radiosensitizers--current status of development of various approaches: report of an International Atomic Energy Agency meetingMichael R Horsman, Lothar Bohm, Geoffrey P Margison, et al.
International Journal of Radiation Biology|July 31, 2010
Human papillomavirus 16 E6 increases the radiosensitivity of p53-mutated cervical cancer cells, associated with up-regulation of aurora AHye-Jin Shin, Joo-Young Kim, Lynne Hampson, et al.
International Journal of Radiation Oncology, Biology, Physics|July 21, 2005
Molecular markers predicting radiotherapy response: report and recommendations from an International Atomic Energy Agency technical meetingCatharine M L West, Michael J McKay, Tobias Hölscher, et al.
Proceedings. Biological Sciences|September 15, 2017
A restatement of the natural science evidence base concerning the health effects of low-level ionizing radiationAngela R McLean, Ella K Adlen, Elisabeth Cardis, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 25, 2014
A modelled comparison of prostate cancer control rates after high-dose-rate brachytherapy (3145 multicentre patients) combined with, or in contrast to, external-beam radiotherapyStephen A Roberts, Raymond Miralbell, Eduardo H Zubizarreta, et al.
Cardiovascular Research|June 15, 2004
Biological aspects of radiation and drug-eluting stents for the prevention of restenosisJürgen R Sindermann, Vitali Verin, John W Hopewell, et al.
International Journal of Radiation Oncology, Biology, Physics|January 31, 2004
The bioreductive agent RH1 and gamma-irradiation both cause G2/M cell cycle phase arrest and polyploidy in a p53-mutated human breast cancer cell lineJoo-Young Kim, Chul-Hwan Kim, Ian J Stratford, et al.
International Journal of Radiation Oncology, Biology, Physics|April 16, 2003
Prediction of the benefits from dose-escalated hypofractionated intensity-modulated radiotherapy for prostate cancerAli M Amer, Judith Mott, Ranald I Mackay, et al.
Journal of Radiological Protection : Official Journal of the Society for Radiological Protection|May 21, 2009
Human exposure to high natural background radiation: what can it teach us about radiation risks?Jolyon H Hendry, Steven L Simon, Andrzej Wojcik, et al.
International Journal of Radiation Oncology, Biology, Physics|January 18, 2006
Tumor radiosensitizers--current status of development of various approaches: report of an International Atomic Energy Agency meetingMichael R Horsman, Lothar Bohm, Geoffrey P Margison, et al.
International Journal of Radiation Biology|July 31, 2010
Human papillomavirus 16 E6 increases the radiosensitivity of p53-mutated cervical cancer cells, associated with up-regulation of aurora AHye-Jin Shin, Joo-Young Kim, Lynne Hampson, et al.
International Journal of Radiation Oncology, Biology, Physics|July 21, 2005
Molecular markers predicting radiotherapy response: report and recommendations from an International Atomic Energy Agency technical meetingCatharine M L West, Michael J McKay, Tobias Hölscher, et al.
Proceedings. Biological Sciences|September 15, 2017
A restatement of the natural science evidence base concerning the health effects of low-level ionizing radiationAngela R McLean, Ella K Adlen, Elisabeth Cardis, et al.
Pageof 2